Literature DB >> 15919259

Current status of cellular therapy for ischemic heart disease.

Shafie Fazel1, Gilbert H L Tang, Denis Angoulvant, Massimo Cimini, Richard D Weisel, Ren-Ke Li, Terrence M Yau.   

Abstract

Cellular therapy for acute myocardial infarction and ischemic cardiomyopathy has entered clinical trials across the globe. Early promising results have now provided the justification for larger randomized and blinded trials to address the efficacy of cellular therapy. A variety of fresh or cultured autologous cells have been delivered by catheter-guided endocardial, catheter-guided intracoronary, catheter-guided transvenous, and direct epicardial routes. This review will summarize the clinical data and highlight salient basic science data that support the ongoing efforts to identify the optimal cellular therapy both for acute myocardial infarction and chronic ischemic cardiomyopathy patients.

Entities:  

Mesh：

Year:  2005        PMID： 15919259     DOI： 10.1016/j.athoracsur.2005.02.085

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  7 in total

Review 1.  Stem cells: An eventual treatment option for heart diseases.

Authors:  Joseph C Bilgimol; Subbareddy Ragupathi; Lakshmanan Vengadassalapathy; Nathan S Senthil; Kalimuthu Selvakumar; M Ganesan; Sadananda Rao Manjunath
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

Review 2.  Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions.

Authors:  Darwin J Prockop; Scott D Olson
Journal:  Blood       Date:  2006-12-14       Impact factor: 22.113

3.  Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines.

Authors:  Shafie Fazel; Massimo Cimini; Liwen Chen; Shuhong Li; Denis Angoulvant; Paul Fedak; Subodh Verma; Richard D Weisel; Armand Keating; Ren-Ke Li
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

Review 4.  Regenerative medicine as applied to general surgery.

Authors:  Giuseppe Orlando; Kathryn J Wood; Paolo De Coppi; Pedro M Baptista; Kyle W Binder; Khalil N Bitar; Christopher Breuer; Luke Burnett; George Christ; Alan Farney; Marina Figliuzzi; James H Holmes; Kenneth Koch; Paolo Macchiarini; Sayed-Hadi Mirmalek Sani; Emmanuel Opara; Andrea Remuzzi; Jeffrey Rogers; Justin M Saul; Dror Seliktar; Keren Shapira-Schweitzer; Tom Smith; Daniel Solomon; Mark Van Dyke; James J Yoo; Yuanyuan Zhang; Anthony Atala; Robert J Stratta; Shay Soker
Journal:  Ann Surg       Date:  2012-05       Impact factor: 12.969

5.  Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.

Authors:  Ryang Hwa Lee; Min Jeong Seo; Roxanne L Reger; Jeffrey L Spees; Andrey A Pulin; Scott D Olson; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-06       Impact factor: 11.205

6.  Cardioprotective C-kit⁺ bone marrow cells attenuate apoptosis after acute myocardial infarction in mice - in-vivo assessment with fluorescence molecular imaging.

Authors:  Angelique Ale; Frank Siebenhaar; Katja Kosanke; Michaela Aichler; Karin Radrich; Sina Heydrich; Matthias Schiemann; Isabella Bielicki; Peter B Noel; Rickmer Braren; Marcus Maurer; Axel K Walch; Ernst J Rummeny; Vasilis Ntziachristos; Moritz Wildgruber
Journal:  Theranostics       Date:  2013-11-02       Impact factor: 11.556

Review 7.  Ultrasound-targeted microbubble destruction in gene therapy: A new tool to cure human diseases.

Authors:  Jun Wu; Ren-Ke Li
Journal:  Genes Dis       Date:  2016-08-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.